Edwards Lifesciences (NYSE: EW) shares tumbled over 8% in after-hours trading after the company's latest earnings and guidance announcement disappointed ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE